by Eli Lilly
Eligible for BMI of 27* or 30 kg/m²*Check Eligibility
*Appointments after 1st of September will incur a different charge. We will update the prices again on 1st of September
Mounjaro (tirzepatide) is an innovative injectable prescription medication for chronic weight management in adults. It combines the effects of GIP and GLP-1 hormones to regulate appetite and improve metabolic function.
As the first dual GIP and GLP-1 receptor agonist, Mounjaro offers superior weight loss results compared to single-action medications. It targets multiple pathways involved in weight regulation for comprehensive effects.
Clinical trials show Mounjaro can help patients lose up to 22% of their body weight when combined with lifestyle changes. The medication follows a structured dose escalation to optimize tolerability.
Mounjaro is approved for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related conditions like type 2 diabetes.
Mounjaro treatment typically begins with a 4-week dose escalation period at 2.5mg before increasing in 2.5mg increments every 4 weeks until reaching the target maintenance dose (ranging from 5mg to 15mg weekly based on individual response). This gradual titration helps minimize gastrointestinal side effects.
Mounjaro is a prescription-only medication. You'll need to complete a consultation with one of our healthcare professionals to determine if it's suitable for you.
Common questions about Mounjaro (tirzepatide) treatment at our Timperley pharmacy.
Mounjaro (tirzepatide) is a once-weekly injection that acts on two gut-hormone pathways (GLP-1 and GIP) to reduce appetite and help you feel fuller for longer, supporting steady weight loss alongside diet and lifestyle changes.
Results vary, but in clinical trials people lost a significant proportion of their body weight over several months when treatment was combined with a reduced-calorie diet and increased activity. Your pharmacist will set realistic expectations for you.
Mounjaro starts at a low dose and is increased gradually (titrated) according to the manufacturer's schedule and how you respond. Your pharmacist confirms each dose increase at your monthly face-to-face review.
The most common side effects are nausea, constipation or diarrhoea and reduced appetite — usually mild and improving over time. Gradual dose increases help limit them, and your monthly review is there to manage anything you experience.
As a general private guide, Mounjaro may be suitable with a BMI of 30 or above, or 27 or above with a weight-related condition. It isn't suitable in pregnancy or breastfeeding. A pharmacist confirms suitability at your face-to-face assessment.
Pricing depends on your dose and is shown on this page and confirmed at your consultation. There are no hidden fees, and your monthly face-to-face reviews are included.
WeightGone